nodes	percent_of_prediction	percent_of_DWPC	metapath
Topotecan—Irinotecan—pancreatic cancer	0.376	1	CrCtD
Topotecan—Topoisomerase Inhibitors—Irinotecan—pancreatic cancer	0.192	0.49	CiPCiCtD
Topotecan—Topoisomerase Inhibitors—Epirubicin—pancreatic cancer	0.104	0.265	CiPCiCtD
Topotecan—Topoisomerase Inhibitors—Doxorubicin—pancreatic cancer	0.096	0.245	CiPCiCtD
Topotecan—TOP1MT—Irinotecan—pancreatic cancer	0.0891	0.473	CbGbCtD
Topotecan—TOP1—Irinotecan—pancreatic cancer	0.0512	0.272	CbGbCtD
Topotecan—ABCG2—Tamoxifen—pancreatic cancer	0.00632	0.0336	CbGbCtD
Topotecan—ABCG2—Erlotinib—pancreatic cancer	0.00537	0.0285	CbGbCtD
Topotecan—ABCG2—Irinotecan—pancreatic cancer	0.00485	0.0258	CbGbCtD
Topotecan—ABCG2—Fluorouracil—pancreatic cancer	0.00466	0.0247	CbGbCtD
Topotecan—ABCG2—Docetaxel—pancreatic cancer	0.00356	0.0189	CbGbCtD
Topotecan—ABCG2—Sunitinib—pancreatic cancer	0.00354	0.0188	CbGbCtD
Topotecan—ABCG2—Doxorubicin—pancreatic cancer	0.00265	0.0141	CbGbCtD
Topotecan—ABCB1—Tamoxifen—pancreatic cancer	0.00228	0.0121	CbGbCtD
Topotecan—ABCB1—Gemcitabine—pancreatic cancer	0.00196	0.0104	CbGbCtD
Topotecan—ABCB1—Erlotinib—pancreatic cancer	0.00194	0.0103	CbGbCtD
Topotecan—ABCB1—Irinotecan—pancreatic cancer	0.00175	0.00929	CbGbCtD
Topotecan—CYP3A4—Tamoxifen—pancreatic cancer	0.00137	0.00725	CbGbCtD
Topotecan—ABCB1—Docetaxel—pancreatic cancer	0.00128	0.00681	CbGbCtD
Topotecan—ABCB1—Sunitinib—pancreatic cancer	0.00128	0.00678	CbGbCtD
Topotecan—CYP3A4—Erlotinib—pancreatic cancer	0.00116	0.00616	CbGbCtD
Topotecan—CYP3A4—Irinotecan—pancreatic cancer	0.00105	0.00557	CbGbCtD
Topotecan—ABCB1—Doxorubicin—pancreatic cancer	0.000956	0.00508	CbGbCtD
Topotecan—CYP3A4—Docetaxel—pancreatic cancer	0.000768	0.00408	CbGbCtD
Topotecan—CYP3A4—Sunitinib—pancreatic cancer	0.000765	0.00406	CbGbCtD
Topotecan—CYP3A4—Doxorubicin—pancreatic cancer	0.000573	0.00304	CbGbCtD
Topotecan—TOP1—Caspase Cascade in Apoptosis—TNFRSF10B—pancreatic cancer	0.000278	0.0798	CbGpPWpGaD
Topotecan—TOP1—Caspase Cascade in Apoptosis—TNFSF10—pancreatic cancer	0.000186	0.0532	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—TFF1—pancreatic cancer	0.000184	0.0528	CbGpPWpGaD
Topotecan—ABCG2—Fluoropyrimidine Activity—SLC29A1—pancreatic cancer	0.000181	0.0518	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—DAXX—pancreatic cancer	0.000134	0.0383	CbGpPWpGaD
Topotecan—TOP1—Caspase Cascade in Apoptosis—BCL2L1—pancreatic cancer	0.000116	0.0333	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—WT1—pancreatic cancer	9.43e-05	0.027	CbGpPWpGaD
Topotecan—TOP1—Circadian rythm related genes—AHR—pancreatic cancer	9.29e-05	0.0266	CbGpPWpGaD
Topotecan—ABCG2—Fluoropyrimidine Activity—TYMP—pancreatic cancer	9.07e-05	0.026	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—SHH—pancreatic cancer	8.46e-05	0.0242	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—IAPP—pancreatic cancer	8.36e-05	0.0239	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	7.3e-05	0.0209	CbGpPWpGaD
Topotecan—TOP1—Caspase Cascade in Apoptosis—CASP3—pancreatic cancer	7.2e-05	0.0206	CbGpPWpGaD
Topotecan—ABCG2—Fluoropyrimidine Activity—DPYD—pancreatic cancer	7.19e-05	0.0206	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	7.18e-05	0.0206	CbGpPWpGaD
Topotecan—TOP1—Circadian rythm related genes—EZH2—pancreatic cancer	7.01e-05	0.0201	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	6.15e-05	0.0176	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	5.56e-05	0.0159	CbGpPWpGaD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—NDRG1—pancreatic cancer	5.54e-05	0.0159	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	5.38e-05	0.0154	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	5.29e-05	0.0151	CbGpPWpGaD
Topotecan—TOP1—Caspase Cascade in Apoptosis—TNF—pancreatic cancer	5.23e-05	0.015	CbGpPWpGaD
Topotecan—TOP1—Circadian rythm related genes—TYMS—pancreatic cancer	5.08e-05	0.0145	CbGpPWpGaD
Topotecan—ABCG2—Fluoropyrimidine Activity—TYMS—pancreatic cancer	4.1e-05	0.0117	CbGpPWpGaD
Topotecan—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—GADD45A—pancreatic cancer	4.06e-05	0.0116	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	4.01e-05	0.0115	CbGpPWpGaD
Topotecan—TOP1—Caspase Cascade in Apoptosis—AKT1—pancreatic cancer	3.9e-05	0.0112	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	3.84e-05	0.011	CbGpPWpGaD
Topotecan—TOP1—Circadian rythm related genes—PPARG—pancreatic cancer	3.6e-05	0.0103	CbGpPWpGaD
Topotecan—Headache—Tamoxifen—pancreatic cancer	3.3e-05	0.000828	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	3.3e-05	0.000828	CcSEcCtD
Topotecan—Rash—Erlotinib—pancreatic cancer	3.29e-05	0.000825	CcSEcCtD
Topotecan—Dermatitis—Erlotinib—pancreatic cancer	3.28e-05	0.000824	CcSEcCtD
Topotecan—Angiopathy—Docetaxel—pancreatic cancer	3.28e-05	0.000824	CcSEcCtD
Topotecan—Dyspepsia—Irinotecan—pancreatic cancer	3.27e-05	0.000821	CcSEcCtD
Topotecan—Immune system disorder—Docetaxel—pancreatic cancer	3.27e-05	0.00082	CcSEcCtD
Topotecan—Headache—Erlotinib—pancreatic cancer	3.27e-05	0.00082	CcSEcCtD
Topotecan—Mediastinal disorder—Docetaxel—pancreatic cancer	3.26e-05	0.000818	CcSEcCtD
Topotecan—Paraesthesia—Gemcitabine—pancreatic cancer	3.25e-05	0.000816	CcSEcCtD
Topotecan—Chills—Docetaxel—pancreatic cancer	3.24e-05	0.000815	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	3.24e-05	0.000814	CcSEcCtD
Topotecan—Asthenia—Sunitinib—pancreatic cancer	3.24e-05	0.000813	CcSEcCtD
Topotecan—Decreased appetite—Irinotecan—pancreatic cancer	3.23e-05	0.000811	CcSEcCtD
Topotecan—Dyspnoea—Gemcitabine—pancreatic cancer	3.23e-05	0.00081	CcSEcCtD
Topotecan—Gastrointestinal disorder—Irinotecan—pancreatic cancer	3.21e-05	0.000805	CcSEcCtD
Topotecan—Fatigue—Irinotecan—pancreatic cancer	3.2e-05	0.000804	CcSEcCtD
Topotecan—Paraesthesia—Fluorouracil—pancreatic cancer	3.2e-05	0.000802	CcSEcCtD
Topotecan—Alopecia—Docetaxel—pancreatic cancer	3.2e-05	0.000802	CcSEcCtD
Topotecan—Pruritus—Sunitinib—pancreatic cancer	3.19e-05	0.000801	CcSEcCtD
Topotecan—ABCG2—HIF-2-alpha transcription factor network—KDR—pancreatic cancer	3.19e-05	0.00913	CbGpPWpGaD
Topotecan—Constipation—Irinotecan—pancreatic cancer	3.18e-05	0.000798	CcSEcCtD
Topotecan—Pain—Irinotecan—pancreatic cancer	3.18e-05	0.000798	CcSEcCtD
Topotecan—Aspartate aminotransferase increased—Epirubicin—pancreatic cancer	3.17e-05	0.000797	CcSEcCtD
Topotecan—Dyspnoea—Fluorouracil—pancreatic cancer	3.17e-05	0.000797	CcSEcCtD
Topotecan—Malnutrition—Docetaxel—pancreatic cancer	3.15e-05	0.00079	CcSEcCtD
Topotecan—Decreased appetite—Gemcitabine—pancreatic cancer	3.15e-05	0.00079	CcSEcCtD
Topotecan—Dyspepsia—Fluorouracil—pancreatic cancer	3.13e-05	0.000787	CcSEcCtD
Topotecan—Nausea—Tamoxifen—pancreatic cancer	3.13e-05	0.000785	CcSEcCtD
Topotecan—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	3.13e-05	0.000785	CcSEcCtD
Topotecan—Fatigue—Gemcitabine—pancreatic cancer	3.12e-05	0.000784	CcSEcCtD
Topotecan—Alanine aminotransferase increased—Epirubicin—pancreatic cancer	3.11e-05	0.000781	CcSEcCtD
Topotecan—Cardiac arrest—Doxorubicin—pancreatic cancer	3.1e-05	0.000779	CcSEcCtD
Topotecan—Constipation—Gemcitabine—pancreatic cancer	3.1e-05	0.000777	CcSEcCtD
Topotecan—Pain—Gemcitabine—pancreatic cancer	3.1e-05	0.000777	CcSEcCtD
Topotecan—Nausea—Erlotinib—pancreatic cancer	3.1e-05	0.000777	CcSEcCtD
Topotecan—Decreased appetite—Fluorouracil—pancreatic cancer	3.09e-05	0.000777	CcSEcCtD
Topotecan—Diarrhoea—Sunitinib—pancreatic cancer	3.09e-05	0.000775	CcSEcCtD
Topotecan—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	3.07e-05	0.000771	CcSEcCtD
Topotecan—Feeling abnormal—Irinotecan—pancreatic cancer	3.06e-05	0.000769	CcSEcCtD
Topotecan—Back pain—Docetaxel—pancreatic cancer	3.04e-05	0.000764	CcSEcCtD
Topotecan—Pain—Fluorouracil—pancreatic cancer	3.04e-05	0.000764	CcSEcCtD
Topotecan—Gastrointestinal pain—Irinotecan—pancreatic cancer	3.04e-05	0.000763	CcSEcCtD
Topotecan—Muscle spasms—Docetaxel—pancreatic cancer	3.03e-05	0.00076	CcSEcCtD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—NDRG1—pancreatic cancer	3e-05	0.00858	CbGpPWpGaD
Topotecan—Dizziness—Sunitinib—pancreatic cancer	2.98e-05	0.000749	CcSEcCtD
Topotecan—Feeling abnormal—Gemcitabine—pancreatic cancer	2.98e-05	0.000749	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	2.95e-05	0.00844	CbGpPWpGaD
Topotecan—Abdominal pain—Irinotecan—pancreatic cancer	2.94e-05	0.000738	CcSEcCtD
Topotecan—Body temperature increased—Irinotecan—pancreatic cancer	2.94e-05	0.000738	CcSEcCtD
Topotecan—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	2.94e-05	0.000737	CcSEcCtD
Topotecan—Feeling abnormal—Fluorouracil—pancreatic cancer	2.93e-05	0.000736	CcSEcCtD
Topotecan—Anaemia—Docetaxel—pancreatic cancer	2.91e-05	0.00073	CcSEcCtD
Topotecan—Pancytopenia—Epirubicin—pancreatic cancer	2.89e-05	0.000726	CcSEcCtD
Topotecan—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	2.88e-05	0.000722	CcSEcCtD
Topotecan—Vomiting—Sunitinib—pancreatic cancer	2.87e-05	0.00072	CcSEcCtD
Topotecan—Body temperature increased—Gemcitabine—pancreatic cancer	2.86e-05	0.000718	CcSEcCtD
Topotecan—Neutropenia—Epirubicin—pancreatic cancer	2.85e-05	0.000715	CcSEcCtD
Topotecan—Rash—Sunitinib—pancreatic cancer	2.84e-05	0.000714	CcSEcCtD
Topotecan—Dermatitis—Sunitinib—pancreatic cancer	2.84e-05	0.000713	CcSEcCtD
Topotecan—Urticaria—Fluorouracil—pancreatic cancer	2.83e-05	0.00071	CcSEcCtD
Topotecan—Headache—Sunitinib—pancreatic cancer	2.83e-05	0.00071	CcSEcCtD
Topotecan—Leukopenia—Docetaxel—pancreatic cancer	2.82e-05	0.000707	CcSEcCtD
Topotecan—Body temperature increased—Fluorouracil—pancreatic cancer	2.81e-05	0.000706	CcSEcCtD
Topotecan—Weight increased—Epirubicin—pancreatic cancer	2.77e-05	0.000696	CcSEcCtD
Topotecan—Cough—Docetaxel—pancreatic cancer	2.75e-05	0.00069	CcSEcCtD
Topotecan—Hypersensitivity—Irinotecan—pancreatic cancer	2.74e-05	0.000687	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	2.74e-05	0.00783	CbGpPWpGaD
Topotecan—Pneumonia—Epirubicin—pancreatic cancer	2.73e-05	0.000686	CcSEcCtD
Topotecan—Infestation NOS—Epirubicin—pancreatic cancer	2.72e-05	0.000682	CcSEcCtD
Topotecan—Infestation—Epirubicin—pancreatic cancer	2.72e-05	0.000682	CcSEcCtD
Topotecan—Myalgia—Docetaxel—pancreatic cancer	2.68e-05	0.000673	CcSEcCtD
Topotecan—Arthralgia—Docetaxel—pancreatic cancer	2.68e-05	0.000673	CcSEcCtD
Topotecan—Chest pain—Docetaxel—pancreatic cancer	2.68e-05	0.000673	CcSEcCtD
Topotecan—Nausea—Sunitinib—pancreatic cancer	2.68e-05	0.000673	CcSEcCtD
Topotecan—Pancytopenia—Doxorubicin—pancreatic cancer	2.68e-05	0.000672	CcSEcCtD
Topotecan—Asthenia—Irinotecan—pancreatic cancer	2.67e-05	0.000669	CcSEcCtD
Topotecan—Neuropathy peripheral—Epirubicin—pancreatic cancer	2.66e-05	0.000669	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	2.66e-05	0.00763	CbGpPWpGaD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	2.66e-05	0.000668	CcSEcCtD
Topotecan—Stomatitis—Epirubicin—pancreatic cancer	2.65e-05	0.000665	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	2.64e-05	0.00755	CbGpPWpGaD
Topotecan—Neutropenia—Doxorubicin—pancreatic cancer	2.64e-05	0.000662	CcSEcCtD
Topotecan—Hypersensitivity—Fluorouracil—pancreatic cancer	2.62e-05	0.000658	CcSEcCtD
Topotecan—Sweating—Epirubicin—pancreatic cancer	2.6e-05	0.000654	CcSEcCtD
Topotecan—Asthenia—Gemcitabine—pancreatic cancer	2.6e-05	0.000652	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	2.57e-05	0.00736	CbGpPWpGaD
Topotecan—Hepatobiliary disease—Epirubicin—pancreatic cancer	2.57e-05	0.000645	CcSEcCtD
Topotecan—Anaphylactic shock—Docetaxel—pancreatic cancer	2.57e-05	0.000645	CcSEcCtD
Topotecan—Weight increased—Doxorubicin—pancreatic cancer	2.57e-05	0.000644	CcSEcCtD
Topotecan—Epistaxis—Epirubicin—pancreatic cancer	2.56e-05	0.000643	CcSEcCtD
Topotecan—Pruritus—Gemcitabine—pancreatic cancer	2.56e-05	0.000643	CcSEcCtD
Topotecan—Infection—Docetaxel—pancreatic cancer	2.55e-05	0.000641	CcSEcCtD
Topotecan—Diarrhoea—Irinotecan—pancreatic cancer	2.54e-05	0.000638	CcSEcCtD
Topotecan—Pneumonia—Doxorubicin—pancreatic cancer	2.53e-05	0.000635	CcSEcCtD
Topotecan—Nervous system disorder—Docetaxel—pancreatic cancer	2.52e-05	0.000632	CcSEcCtD
Topotecan—Pruritus—Fluorouracil—pancreatic cancer	2.52e-05	0.000632	CcSEcCtD
Topotecan—Thrombocytopenia—Docetaxel—pancreatic cancer	2.52e-05	0.000631	CcSEcCtD
Topotecan—Infestation—Doxorubicin—pancreatic cancer	2.51e-05	0.000631	CcSEcCtD
Topotecan—Infestation NOS—Doxorubicin—pancreatic cancer	2.51e-05	0.000631	CcSEcCtD
Topotecan—Skin disorder—Docetaxel—pancreatic cancer	2.5e-05	0.000626	CcSEcCtD
Topotecan—Diarrhoea—Gemcitabine—pancreatic cancer	2.48e-05	0.000622	CcSEcCtD
Topotecan—TOP1—Circadian rythm related genes—PTEN—pancreatic cancer	2.47e-05	0.00707	CbGpPWpGaD
Topotecan—Neuropathy peripheral—Doxorubicin—pancreatic cancer	2.46e-05	0.000619	CcSEcCtD
Topotecan—Dizziness—Irinotecan—pancreatic cancer	2.46e-05	0.000617	CcSEcCtD
Topotecan—Haemoglobin—Epirubicin—pancreatic cancer	2.45e-05	0.000615	CcSEcCtD
Topotecan—Stomatitis—Doxorubicin—pancreatic cancer	2.45e-05	0.000615	CcSEcCtD
Topotecan—Anorexia—Docetaxel—pancreatic cancer	2.45e-05	0.000615	CcSEcCtD
Topotecan—Rhinitis—Epirubicin—pancreatic cancer	2.45e-05	0.000614	CcSEcCtD
Topotecan—Haemorrhage—Epirubicin—pancreatic cancer	2.44e-05	0.000612	CcSEcCtD
Topotecan—Diarrhoea—Fluorouracil—pancreatic cancer	2.44e-05	0.000611	CcSEcCtD
Topotecan—Hypoaesthesia—Epirubicin—pancreatic cancer	2.43e-05	0.000609	CcSEcCtD
Topotecan—Pharyngitis—Epirubicin—pancreatic cancer	2.42e-05	0.000608	CcSEcCtD
Topotecan—Sweating—Doxorubicin—pancreatic cancer	2.41e-05	0.000605	CcSEcCtD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—SMAD4—pancreatic cancer	2.4e-05	0.00687	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	2.38e-05	0.00683	CbGpPWpGaD
Topotecan—Hepatobiliary disease—Doxorubicin—pancreatic cancer	2.38e-05	0.000597	CcSEcCtD
Topotecan—Epistaxis—Doxorubicin—pancreatic cancer	2.37e-05	0.000595	CcSEcCtD
Topotecan—Vomiting—Irinotecan—pancreatic cancer	2.36e-05	0.000593	CcSEcCtD
Topotecan—Dizziness—Fluorouracil—pancreatic cancer	2.35e-05	0.000591	CcSEcCtD
Topotecan—Rash—Irinotecan—pancreatic cancer	2.34e-05	0.000588	CcSEcCtD
Topotecan—Dermatitis—Irinotecan—pancreatic cancer	2.34e-05	0.000588	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	2.34e-05	0.000588	CcSEcCtD
Topotecan—Headache—Irinotecan—pancreatic cancer	2.33e-05	0.000584	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	2.32e-05	0.00665	CbGpPWpGaD
Topotecan—Paraesthesia—Docetaxel—pancreatic cancer	2.31e-05	0.000579	CcSEcCtD
Topotecan—Vomiting—Gemcitabine—pancreatic cancer	2.3e-05	0.000578	CcSEcCtD
Topotecan—Dyspnoea—Docetaxel—pancreatic cancer	2.29e-05	0.000575	CcSEcCtD
Topotecan—Rash—Gemcitabine—pancreatic cancer	2.28e-05	0.000573	CcSEcCtD
Topotecan—Dermatitis—Gemcitabine—pancreatic cancer	2.28e-05	0.000572	CcSEcCtD
Topotecan—Haemoglobin—Doxorubicin—pancreatic cancer	2.27e-05	0.000569	CcSEcCtD
Topotecan—Headache—Gemcitabine—pancreatic cancer	2.27e-05	0.000569	CcSEcCtD
Topotecan—Vomiting—Fluorouracil—pancreatic cancer	2.26e-05	0.000568	CcSEcCtD
Topotecan—Rhinitis—Doxorubicin—pancreatic cancer	2.26e-05	0.000568	CcSEcCtD
Topotecan—Dyspepsia—Docetaxel—pancreatic cancer	2.26e-05	0.000568	CcSEcCtD
Topotecan—Haemorrhage—Doxorubicin—pancreatic cancer	2.26e-05	0.000567	CcSEcCtD
Topotecan—Hypoaesthesia—Doxorubicin—pancreatic cancer	2.25e-05	0.000564	CcSEcCtD
Topotecan—Rash—Fluorouracil—pancreatic cancer	2.24e-05	0.000563	CcSEcCtD
Topotecan—Dermatitis—Fluorouracil—pancreatic cancer	2.24e-05	0.000563	CcSEcCtD
Topotecan—Pharyngitis—Doxorubicin—pancreatic cancer	2.24e-05	0.000562	CcSEcCtD
Topotecan—Decreased appetite—Docetaxel—pancreatic cancer	2.23e-05	0.000561	CcSEcCtD
Topotecan—Headache—Fluorouracil—pancreatic cancer	2.23e-05	0.00056	CcSEcCtD
Topotecan—Gastrointestinal disorder—Docetaxel—pancreatic cancer	2.22e-05	0.000557	CcSEcCtD
Topotecan—Fatigue—Docetaxel—pancreatic cancer	2.21e-05	0.000556	CcSEcCtD
Topotecan—Angiopathy—Epirubicin—pancreatic cancer	2.21e-05	0.000556	CcSEcCtD
Topotecan—Nausea—Irinotecan—pancreatic cancer	2.21e-05	0.000554	CcSEcCtD
Topotecan—Immune system disorder—Epirubicin—pancreatic cancer	2.2e-05	0.000553	CcSEcCtD
Topotecan—Mediastinal disorder—Epirubicin—pancreatic cancer	2.2e-05	0.000552	CcSEcCtD
Topotecan—Pain—Docetaxel—pancreatic cancer	2.2e-05	0.000552	CcSEcCtD
Topotecan—Constipation—Docetaxel—pancreatic cancer	2.2e-05	0.000552	CcSEcCtD
Topotecan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—GADD45A—pancreatic cancer	2.19e-05	0.00628	CbGpPWpGaD
Topotecan—Chills—Epirubicin—pancreatic cancer	2.19e-05	0.000549	CcSEcCtD
Topotecan—ABCG2—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	2.16e-05	0.00619	CbGpPWpGaD
Topotecan—Alopecia—Epirubicin—pancreatic cancer	2.16e-05	0.000541	CcSEcCtD
Topotecan—Nausea—Gemcitabine—pancreatic cancer	2.15e-05	0.00054	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	2.14e-05	0.00612	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	2.13e-05	0.0061	CbGpPWpGaD
Topotecan—Malnutrition—Epirubicin—pancreatic cancer	2.12e-05	0.000533	CcSEcCtD
Topotecan—Feeling abnormal—Docetaxel—pancreatic cancer	2.12e-05	0.000531	CcSEcCtD
Topotecan—Nausea—Fluorouracil—pancreatic cancer	2.11e-05	0.000531	CcSEcCtD
Topotecan—Gastrointestinal pain—Docetaxel—pancreatic cancer	2.1e-05	0.000527	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	2.09e-05	0.00598	CbGpPWpGaD
Topotecan—Back pain—Epirubicin—pancreatic cancer	2.05e-05	0.000516	CcSEcCtD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—TERT—pancreatic cancer	2.05e-05	0.00587	CbGpPWpGaD
Topotecan—Angiopathy—Doxorubicin—pancreatic cancer	2.05e-05	0.000514	CcSEcCtD
Topotecan—Muscle spasms—Epirubicin—pancreatic cancer	2.04e-05	0.000512	CcSEcCtD
Topotecan—Immune system disorder—Doxorubicin—pancreatic cancer	2.04e-05	0.000512	CcSEcCtD
Topotecan—Mediastinal disorder—Doxorubicin—pancreatic cancer	2.03e-05	0.000511	CcSEcCtD
Topotecan—Body temperature increased—Docetaxel—pancreatic cancer	2.03e-05	0.00051	CcSEcCtD
Topotecan—Abdominal pain—Docetaxel—pancreatic cancer	2.03e-05	0.00051	CcSEcCtD
Topotecan—Chills—Doxorubicin—pancreatic cancer	2.02e-05	0.000508	CcSEcCtD
Topotecan—Alopecia—Doxorubicin—pancreatic cancer	1.99e-05	0.000501	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	1.99e-05	0.0057	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	1.97e-05	0.00565	CbGpPWpGaD
Topotecan—Ill-defined disorder—Epirubicin—pancreatic cancer	1.97e-05	0.000495	CcSEcCtD
Topotecan—Malnutrition—Doxorubicin—pancreatic cancer	1.96e-05	0.000493	CcSEcCtD
Topotecan—Anaemia—Epirubicin—pancreatic cancer	1.96e-05	0.000493	CcSEcCtD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—HIF1A—pancreatic cancer	1.96e-05	0.00562	CbGpPWpGaD
Topotecan—Malaise—Epirubicin—pancreatic cancer	1.91e-05	0.000481	CcSEcCtD
Topotecan—Leukopenia—Epirubicin—pancreatic cancer	1.9e-05	0.000477	CcSEcCtD
Topotecan—Back pain—Doxorubicin—pancreatic cancer	1.9e-05	0.000477	CcSEcCtD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TFF1—pancreatic cancer	1.9e-05	0.00543	CbGpPWpGaD
Topotecan—Hypersensitivity—Docetaxel—pancreatic cancer	1.89e-05	0.000475	CcSEcCtD
Topotecan—Muscle spasms—Doxorubicin—pancreatic cancer	1.89e-05	0.000474	CcSEcCtD
Topotecan—Cough—Epirubicin—pancreatic cancer	1.85e-05	0.000465	CcSEcCtD
Topotecan—Asthenia—Docetaxel—pancreatic cancer	1.84e-05	0.000463	CcSEcCtD
Topotecan—Ill-defined disorder—Doxorubicin—pancreatic cancer	1.82e-05	0.000458	CcSEcCtD
Topotecan—Pruritus—Docetaxel—pancreatic cancer	1.82e-05	0.000456	CcSEcCtD
Topotecan—Anaemia—Doxorubicin—pancreatic cancer	1.82e-05	0.000456	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	1.81e-05	0.00519	CbGpPWpGaD
Topotecan—Myalgia—Epirubicin—pancreatic cancer	1.81e-05	0.000454	CcSEcCtD
Topotecan—Chest pain—Epirubicin—pancreatic cancer	1.81e-05	0.000454	CcSEcCtD
Topotecan—Arthralgia—Epirubicin—pancreatic cancer	1.81e-05	0.000454	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	1.8e-05	0.000451	CcSEcCtD
Topotecan—Discomfort—Epirubicin—pancreatic cancer	1.79e-05	0.000448	CcSEcCtD
Topotecan—Malaise—Doxorubicin—pancreatic cancer	1.77e-05	0.000445	CcSEcCtD
Topotecan—ABCG2—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	1.76e-05	0.00504	CbGpPWpGaD
Topotecan—Leukopenia—Doxorubicin—pancreatic cancer	1.76e-05	0.000441	CcSEcCtD
Topotecan—Diarrhoea—Docetaxel—pancreatic cancer	1.76e-05	0.000441	CcSEcCtD
Topotecan—ABCG2—HIF-2-alpha transcription factor network—VEGFA—pancreatic cancer	1.76e-05	0.00503	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	1.75e-05	0.00502	CbGpPWpGaD
Topotecan—Anaphylactic shock—Epirubicin—pancreatic cancer	1.73e-05	0.000435	CcSEcCtD
Topotecan—Infection—Epirubicin—pancreatic cancer	1.72e-05	0.000432	CcSEcCtD
Topotecan—Cough—Doxorubicin—pancreatic cancer	1.71e-05	0.00043	CcSEcCtD
Topotecan—Nervous system disorder—Epirubicin—pancreatic cancer	1.7e-05	0.000427	CcSEcCtD
Topotecan—Dizziness—Docetaxel—pancreatic cancer	1.7e-05	0.000426	CcSEcCtD
Topotecan—Thrombocytopenia—Epirubicin—pancreatic cancer	1.7e-05	0.000426	CcSEcCtD
Topotecan—TOP1—Circadian rythm related genes—TP53—pancreatic cancer	1.68e-05	0.00482	CbGpPWpGaD
Topotecan—Skin disorder—Epirubicin—pancreatic cancer	1.68e-05	0.000423	CcSEcCtD
Topotecan—Hyperhidrosis—Epirubicin—pancreatic cancer	1.68e-05	0.000421	CcSEcCtD
Topotecan—Chest pain—Doxorubicin—pancreatic cancer	1.67e-05	0.00042	CcSEcCtD
Topotecan—Myalgia—Doxorubicin—pancreatic cancer	1.67e-05	0.00042	CcSEcCtD
Topotecan—Arthralgia—Doxorubicin—pancreatic cancer	1.67e-05	0.00042	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	1.66e-05	0.000417	CcSEcCtD
Topotecan—Discomfort—Doxorubicin—pancreatic cancer	1.65e-05	0.000415	CcSEcCtD
Topotecan—Anorexia—Epirubicin—pancreatic cancer	1.65e-05	0.000415	CcSEcCtD
Topotecan—Vomiting—Docetaxel—pancreatic cancer	1.63e-05	0.00041	CcSEcCtD
Topotecan—Rash—Docetaxel—pancreatic cancer	1.62e-05	0.000407	CcSEcCtD
Topotecan—Dermatitis—Docetaxel—pancreatic cancer	1.62e-05	0.000406	CcSEcCtD
Topotecan—Headache—Docetaxel—pancreatic cancer	1.61e-05	0.000404	CcSEcCtD
Topotecan—Anaphylactic shock—Doxorubicin—pancreatic cancer	1.6e-05	0.000403	CcSEcCtD
Topotecan—Infection—Doxorubicin—pancreatic cancer	1.59e-05	0.0004	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	1.58e-05	0.000396	CcSEcCtD
Topotecan—Nervous system disorder—Doxorubicin—pancreatic cancer	1.57e-05	0.000395	CcSEcCtD
Topotecan—Thrombocytopenia—Doxorubicin—pancreatic cancer	1.57e-05	0.000394	CcSEcCtD
Topotecan—Skin disorder—Doxorubicin—pancreatic cancer	1.56e-05	0.000391	CcSEcCtD
Topotecan—Paraesthesia—Epirubicin—pancreatic cancer	1.56e-05	0.000391	CcSEcCtD
Topotecan—Hyperhidrosis—Doxorubicin—pancreatic cancer	1.55e-05	0.000389	CcSEcCtD
Topotecan—Dyspnoea—Epirubicin—pancreatic cancer	1.54e-05	0.000388	CcSEcCtD
Topotecan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	1.53e-05	0.00439	CbGpPWpGaD
Topotecan—Anorexia—Doxorubicin—pancreatic cancer	1.53e-05	0.000384	CcSEcCtD
Topotecan—Nausea—Docetaxel—pancreatic cancer	1.53e-05	0.000383	CcSEcCtD
Topotecan—Dyspepsia—Epirubicin—pancreatic cancer	1.53e-05	0.000383	CcSEcCtD
Topotecan—Decreased appetite—Epirubicin—pancreatic cancer	1.51e-05	0.000378	CcSEcCtD
Topotecan—Gastrointestinal disorder—Epirubicin—pancreatic cancer	1.5e-05	0.000376	CcSEcCtD
Topotecan—Fatigue—Epirubicin—pancreatic cancer	1.49e-05	0.000375	CcSEcCtD
Topotecan—Pain—Epirubicin—pancreatic cancer	1.48e-05	0.000372	CcSEcCtD
Topotecan—Constipation—Epirubicin—pancreatic cancer	1.48e-05	0.000372	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	1.48e-05	0.00424	CbGpPWpGaD
Topotecan—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	1.46e-05	0.000367	CcSEcCtD
Topotecan—Paraesthesia—Doxorubicin—pancreatic cancer	1.44e-05	0.000361	CcSEcCtD
Topotecan—Dyspnoea—Doxorubicin—pancreatic cancer	1.43e-05	0.000359	CcSEcCtD
Topotecan—Feeling abnormal—Epirubicin—pancreatic cancer	1.43e-05	0.000358	CcSEcCtD
Topotecan—Gastrointestinal pain—Epirubicin—pancreatic cancer	1.42e-05	0.000356	CcSEcCtD
Topotecan—Dyspepsia—Doxorubicin—pancreatic cancer	1.41e-05	0.000354	CcSEcCtD
Topotecan—Decreased appetite—Doxorubicin—pancreatic cancer	1.39e-05	0.00035	CcSEcCtD
Topotecan—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	1.38e-05	0.000347	CcSEcCtD
Topotecan—Fatigue—Doxorubicin—pancreatic cancer	1.38e-05	0.000347	CcSEcCtD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—DAXX—pancreatic cancer	1.38e-05	0.00394	CbGpPWpGaD
Topotecan—Urticaria—Epirubicin—pancreatic cancer	1.38e-05	0.000346	CcSEcCtD
Topotecan—Pain—Doxorubicin—pancreatic cancer	1.37e-05	0.000344	CcSEcCtD
Topotecan—Constipation—Doxorubicin—pancreatic cancer	1.37e-05	0.000344	CcSEcCtD
Topotecan—Abdominal pain—Epirubicin—pancreatic cancer	1.37e-05	0.000344	CcSEcCtD
Topotecan—Body temperature increased—Epirubicin—pancreatic cancer	1.37e-05	0.000344	CcSEcCtD
Topotecan—ABCG2—Fluoropyrimidine Activity—TP53—pancreatic cancer	1.36e-05	0.00389	CbGpPWpGaD
Topotecan—Feeling abnormal—Doxorubicin—pancreatic cancer	1.32e-05	0.000332	CcSEcCtD
Topotecan—Gastrointestinal pain—Doxorubicin—pancreatic cancer	1.31e-05	0.000329	CcSEcCtD
Topotecan—ABCB1—Allograft Rejection—AGTR1—pancreatic cancer	1.3e-05	0.00372	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—SMAD4—pancreatic cancer	1.3e-05	0.00371	CbGpPWpGaD
Topotecan—Hypersensitivity—Epirubicin—pancreatic cancer	1.28e-05	0.00032	CcSEcCtD
Topotecan—Urticaria—Doxorubicin—pancreatic cancer	1.27e-05	0.00032	CcSEcCtD
Topotecan—Body temperature increased—Doxorubicin—pancreatic cancer	1.27e-05	0.000318	CcSEcCtD
Topotecan—Abdominal pain—Doxorubicin—pancreatic cancer	1.27e-05	0.000318	CcSEcCtD
Topotecan—Asthenia—Epirubicin—pancreatic cancer	1.24e-05	0.000312	CcSEcCtD
Topotecan—Pruritus—Epirubicin—pancreatic cancer	1.23e-05	0.000308	CcSEcCtD
Topotecan—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—pancreatic cancer	1.21e-05	0.00346	CbGpPWpGaD
Topotecan—Diarrhoea—Epirubicin—pancreatic cancer	1.19e-05	0.000298	CcSEcCtD
Topotecan—Hypersensitivity—Doxorubicin—pancreatic cancer	1.18e-05	0.000297	CcSEcCtD
Topotecan—ABCB1—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	1.17e-05	0.00335	CbGpPWpGaD
Topotecan—Asthenia—Doxorubicin—pancreatic cancer	1.15e-05	0.000289	CcSEcCtD
Topotecan—Dizziness—Epirubicin—pancreatic cancer	1.15e-05	0.000288	CcSEcCtD
Topotecan—Pruritus—Doxorubicin—pancreatic cancer	1.13e-05	0.000285	CcSEcCtD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—TERT—pancreatic cancer	1.11e-05	0.00318	CbGpPWpGaD
Topotecan—Vomiting—Epirubicin—pancreatic cancer	1.1e-05	0.000277	CcSEcCtD
Topotecan—Diarrhoea—Doxorubicin—pancreatic cancer	1.1e-05	0.000275	CcSEcCtD
Topotecan—Rash—Epirubicin—pancreatic cancer	1.09e-05	0.000274	CcSEcCtD
Topotecan—Dermatitis—Epirubicin—pancreatic cancer	1.09e-05	0.000274	CcSEcCtD
Topotecan—Headache—Epirubicin—pancreatic cancer	1.09e-05	0.000273	CcSEcCtD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—HIF1A—pancreatic cancer	1.06e-05	0.00304	CbGpPWpGaD
Topotecan—Dizziness—Doxorubicin—pancreatic cancer	1.06e-05	0.000266	CcSEcCtD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—VEGFA—pancreatic cancer	1.03e-05	0.00296	CbGpPWpGaD
Topotecan—Nausea—Epirubicin—pancreatic cancer	1.03e-05	0.000258	CcSEcCtD
Topotecan—Vomiting—Doxorubicin—pancreatic cancer	1.02e-05	0.000256	CcSEcCtD
Topotecan—Rash—Doxorubicin—pancreatic cancer	1.01e-05	0.000254	CcSEcCtD
Topotecan—Dermatitis—Doxorubicin—pancreatic cancer	1.01e-05	0.000254	CcSEcCtD
Topotecan—Headache—Doxorubicin—pancreatic cancer	1e-05	0.000252	CcSEcCtD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—pancreatic cancer	9.7e-06	0.00278	CbGpPWpGaD
Topotecan—Nausea—Doxorubicin—pancreatic cancer	9.52e-06	0.000239	CcSEcCtD
Topotecan—ABCB1—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	9.52e-06	0.00273	CbGpPWpGaD
Topotecan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	9.44e-06	0.0027	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—pancreatic cancer	8.7e-06	0.00249	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—IAPP—pancreatic cancer	8.6e-06	0.00246	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	7.51e-06	0.00215	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	7.39e-06	0.00212	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	6.65e-06	0.00191	CbGpPWpGaD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—AKT1—pancreatic cancer	6.59e-06	0.00189	CbGpPWpGaD
Topotecan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—pancreatic cancer	6.52e-06	0.00187	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	6.32e-06	0.00181	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—CXCL8—pancreatic cancer	5.96e-06	0.00171	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	5.72e-06	0.00164	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—CASP3—pancreatic cancer	5.7e-06	0.00163	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—pancreatic cancer	5.59e-06	0.0016	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	5.54e-06	0.00159	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PRSS1—pancreatic cancer	5.46e-06	0.00156	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	5.44e-06	0.00156	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—VEGFA—pancreatic cancer	4.84e-06	0.00139	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ARG2—pancreatic cancer	4.74e-06	0.00136	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—TGFB1—pancreatic cancer	4.44e-06	0.00127	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—TNF—pancreatic cancer	4.15e-06	0.00119	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—TYMP—pancreatic cancer	4.14e-06	0.00119	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	4.12e-06	0.00118	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	3.95e-06	0.00113	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	3.6e-06	0.00103	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—AKT1—pancreatic cancer	3.57e-06	0.00102	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GLP1R—pancreatic cancer	3.34e-06	0.000956	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—DPYD—pancreatic cancer	3.28e-06	0.00094	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—SLC2A2—pancreatic cancer	3.12e-06	0.000892	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	3.03e-06	0.000868	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PRSS1—pancreatic cancer	2.95e-06	0.000846	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	2.81e-06	0.000806	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	2.74e-06	0.000784	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	2.71e-06	0.000777	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	2.64e-06	0.000757	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ARG2—pancreatic cancer	2.56e-06	0.000734	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	2.45e-06	0.000702	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CD44—pancreatic cancer	2.41e-06	0.000691	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	2.39e-06	0.000684	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GCG—pancreatic cancer	2.31e-06	0.000663	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—TYMP—pancreatic cancer	2.24e-06	0.000641	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	2.2e-06	0.000629	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	2.19e-06	0.000628	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—STK11—pancreatic cancer	2.18e-06	0.000623	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	2.15e-06	0.000615	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	2.05e-06	0.000586	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	2.03e-06	0.000581	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—TYMS—pancreatic cancer	1.87e-06	0.000536	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	1.87e-06	0.000534	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PRSS1—pancreatic cancer	1.82e-06	0.000521	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GLP1R—pancreatic cancer	1.8e-06	0.000517	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	1.8e-06	0.000517	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—DPYD—pancreatic cancer	1.78e-06	0.000508	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—SLC2A2—pancreatic cancer	1.68e-06	0.000482	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ARG2—pancreatic cancer	1.58e-06	0.000452	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	1.52e-06	0.000436	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—APOE—pancreatic cancer	1.52e-06	0.000436	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—TYMP—pancreatic cancer	1.38e-06	0.000395	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PIK3CG—pancreatic cancer	1.37e-06	0.000393	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PPARG—pancreatic cancer	1.33e-06	0.00038	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CD44—pancreatic cancer	1.3e-06	0.000374	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GCG—pancreatic cancer	1.25e-06	0.000358	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PIK3CD—pancreatic cancer	1.21e-06	0.000346	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—STK11—pancreatic cancer	1.18e-06	0.000337	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GLP1R—pancreatic cancer	1.11e-06	0.000318	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—DPYD—pancreatic cancer	1.09e-06	0.000313	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PIK3CB—pancreatic cancer	1.05e-06	0.000301	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PTGS2—pancreatic cancer	1.04e-06	0.000299	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	1.04e-06	0.000297	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—TYMS—pancreatic cancer	1.01e-06	0.00029	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PTEN—pancreatic cancer	9.09e-07	0.00026	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—APOE—pancreatic cancer	8.23e-07	0.000236	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CD44—pancreatic cancer	8.04e-07	0.00023	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GCG—pancreatic cancer	7.71e-07	0.000221	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PIK3CG—pancreatic cancer	7.43e-07	0.000213	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—STK11—pancreatic cancer	7.25e-07	0.000208	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PPARG—pancreatic cancer	7.17e-07	0.000205	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PIK3CD—pancreatic cancer	6.53e-07	0.000187	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PIK3CA—pancreatic cancer	6.42e-07	0.000184	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—TYMS—pancreatic cancer	6.23e-07	0.000179	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PIK3CB—pancreatic cancer	5.69e-07	0.000163	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PTGS2—pancreatic cancer	5.64e-07	0.000161	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—AKT1—pancreatic cancer	5.24e-07	0.00015	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—APOE—pancreatic cancer	5.07e-07	0.000145	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PTEN—pancreatic cancer	4.92e-07	0.000141	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	4.57e-07	0.000131	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PPARG—pancreatic cancer	4.42e-07	0.000126	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	4.02e-07	0.000115	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	3.51e-07	0.0001	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PTGS2—pancreatic cancer	3.47e-07	9.95e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PIK3CA—pancreatic cancer	3.47e-07	9.93e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PTEN—pancreatic cancer	3.03e-07	8.67e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—AKT1—pancreatic cancer	2.83e-07	8.11e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	2.14e-07	6.12e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—AKT1—pancreatic cancer	1.75e-07	5e-05	CbGpPWpGaD
